Trademarkia Logo

Australia

AU$
OXRESA
Accepted: In opposition period

Last updated on 24 Apr 2025

Owner Info

Amgen Inc.

One Amgen Center Drive,

Trademark Operations MS-28-5A, UNITED STATES OF AMERICA

Serial Number

2538557 filed on 11 Mar 2025

Correspondent

Elsa D. Lemoine Amgen Inc.

One Amgen Center Drive,,

Trademark Operations MS-28-5A,

UNITED STATES OF AMERICA

OXRESA

Classification Information


Class [005]
Pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical pre Read More

Mark Details


Serial Number

2538557

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

12 Sept 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
24th Apr 2025Application Accepted correspondence sent
23rd Apr 2025IP Right has been Examined
23rd Apr 2025IP Right Acceptance Published
23rd Apr 2025Status change to Accepted
14th Apr 2025Examination expedited
14th Apr 2025Awaiting examination
10th Apr 2025IP Right Filed Published
10th Apr 2025Status change to Published
10th Apr 2025Status change to Filed
10th Apr 2025Application Received